Skip to main content
. 2020 May 18;5(Suppl 3):e000804. doi: 10.1136/esmoopen-2020-000804

Table 2.

Imaging priorities for the management of pancreatic cancer

High priority Medium priority Low priority
Symptomatic patients (intestinal occlusion, jaundice) Restaging after surgical treatment. Routine follow-up assessments outside the context of clinical trials
Diagnostic imaging for clinical suspicion of pancreatic cancer (CT scan, followed by EUS in the case of non-metastatic disease)
Established patients with new problems or symptoms from treatment

CT, computed tomography; EUS, endoscopic ultrasound.